JG
ONC

Jefferies Group’s BeOne Medicines Ltd ONC Stock Holding History

Jefferies Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,200
Closed -$394K – 2143
2020
Q1 		$394K Buy
3,200
+1,400
+78% +$219K ﹤0.01% 1408
2019
Q4 		$298K Sell
1,800
-60,800
-97% -$10.1M ﹤0.01% 2069
2019
Q3 		$7.67M Buy
+62,600
New +$8.31M 0.06% 316
2019
Q2 		– Sell
-10,600
Closed -$1.4M – 2921
2019
Q1 		$1.4M Hold
10,600
– – 0.01% 1096
2018
Q4 		$1.49M Buy
+10,600
New +$1.41M 0.01% 974

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Jefferies Group's ONC Position: Q2 2020 in Review

Jefferies Group sold out of BeOne Medicines Ltd (ONC) in Q2 2020, closing a stake of 16,000 shares — an estimated $1.97M sold.

Jefferies Group first reported a position in ONC in Q4 2017 and held it in 7 quarters. The position peaked at $1.97M in Q1 2020. 220 funds tracked by Wall St. Rank hold ONC as of Q2 2020.

  • Jefferies Group reported no remaining BeOne Medicines Ltd position as of Q2 2020 after selling out during the quarter.
  • Jefferies Group sold 16,000 BeOne Medicines Ltd shares in Q2 2020, an estimated $1.97M.
  • Jefferies Group first reported a position in BeOne Medicines Ltd in Q4 2017 and held it in 7 quarters.
  • Jefferies Group's BeOne Medicines Ltd position peaked at $1.97M in Q1 2020.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2020.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.